CNTO6785

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNTO6785, covering 2016-06-08 to 2016-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing